Board Of Directors
The current composition of the Board is as follows:
Lance J Baller, Non-Executive Chairman
Mr. Baller was co-founder, CEO and President (2010-2013) of Iofina Plc since prior to his departure for health reasons in June 2013. Mr. Baller returned to Iofina plc as Non-Executive Chairman April 2014. Mr. Baller is the former managing partner of The Elevation Fund and Elevation Capital Management. Mr. Baller is the former managing partner of Shortline Equity Partners, Inc., a mid-market merger and acquisitions consulting and investment company in the United States. He has actively served on the investment, audit, corporate governance, and compensation committees, while on the board of directors of companies in Asia and North America. Mr. Baller is also a former vice president of mergers and acquisitions, financing and corporate development at Integrated Biopharma, Inc. and prior to this a vice president of the investment banking firms UBS AG and Morgan Stanley. He has served as Chairman to various companies and has lead successful restructurings. Mr. Baller is on the board of trustees of Index Funds and also serves as the chairman of the audit committee and as the audit committee financial expert under the Sarbanes-Oxley Act of the United States for Index Funds. Mr Baller is Chairman of the Audit Committee and Member of the Compensation Committee.
Dr. Thomas M. Becker, CEO and President
Dr Becker has served as President/CEO of Iofina Chemical since March 2010 during which the iodine derivatives company has experienced record expansion, revenues and profits. Dr. Becker is a recognized expert in the global iodine market and has extensive production knowledge of iodine and iodine derivatives. Dr. Becker holds a PhD from the University of Cincinnati and a BS from Indiana University, both in Chemistry. Prior to Iofina/H&S Chemical, Dr. Becker worked as an Oak Ridge Scholar on behalf of the US EPA and worked for various other chemical manufacturing companies. He has extensive experience in scale-up of chemical processes from laboratory to pilot to full scale production.
Malcolm T. Lewin, CFO
Mr. Lewin is based in the UK and has over 30 years of experience in finance and accounting for both public and private companies. As well as being a partner in a chartered accounting firm for 11 years, he has acted for various companies listed on AIM and other exchanges. In particular, from 2000 to 2003 he was the Finance Director of Oxford Metrics plc, an AIM company supplying motion capture and visual geometry systems. From 2004 to 2006 he was the Finance Director of Real Estate Investors plc, an AIM property investment company with interests in quality commercial and industrial properties. From 2006 to 2011 he was a Director and CFO of Hunter Bay Mineralo Venture Exchange with interests in South America and Canada. From 2011 to 2014 he was CFO and Treasurer of VolitionRX Limited, an OTC life sciences company focused on developing blood tests for a broad range of cancer types and other conditions. Mr. Lewin has an MA in Classics from Oxford University and qualified as a chartered accountant with Coopers & Lybrand.
Dr. William D. Bellamy, Non-Executive Director
Dr. Bellamy is a Fellow and Senior Vice President of the Water Business Group at CH2M HILL, Inc. (“CH2M”), a company he has worked at for 30 years. CH2M is one of the largest consulting engineering companies in the world providing leadership and strategic direction for the water business and application of technologies worldwide. Dr. Bellamy has participated in energy and sustainability forums, including as a panellist at the World Future Energy Conference in Abu Dhabi, the World Bank Sustainable Cities Symposium and the Future of Water Economic Forum. Dr. Bellamy serves as Professor of Practice at the University of Wyoming, where he teaches graduate courses and is responsible for securing grants and research funding in the areas of water resources, water treatment and sustainable energy development. Dr. Bellamy has a PhD in Civil Engineering from Colorado State University, an MSc in Civil (Environmental) Engineering from the University of Wyoming and a BSc in Electrical (Bio-Medical) Engineering from the University of Wyoming. Dr Bellamy is Chairman of the Compensation Committee and Member of the Audit Committee.